This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Accelrys ELN Advances Innovation Lifecycle Management With Enhanced Biology Capabilities From Screening To Preclinical Development

SAN DIEGO, Aug. 28, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced that the latest release of the company's enterprise electronic laboratory notebook (ELN), Symyx Notebook by Accelrys, offers a new multidimensional scientific spreadsheet for use in planning, executing and tracking a wide range of biological experiments. In addition, powerful new project tracking and optimization software provides a more complete biology solution, from efficient study orchestration to study execution in the lab. Together, the new ELN capabilities accelerate scientific innovation lifecycle management across a range of chemical and biological experimentation, helping bridge the productivity gap from innovation through commercialization.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-eln-advances-innovation-lifecycle-management-with-enhanced-biology-capabilities-from-screening-to-preclinical-development-167625565.html  

By significantly improving bench scientists' ability to capture, mine and reuse experiment and study information from within the ELN, the new scientific spreadsheet improves data access, enhances knowledge management and reduces laboratory cycle times. The new project tracking and optimization capabilities improve collaboration and cascade management for project teams while enhancing study visibility and capacity management for study directors.

"The new spreadsheet and unique project tracking capabilities accelerate end-to-end innovation productivity for discovery and development scientists, especially those working in preclinical development," said Accelrys' Senior Vice President and Chief Technology Officer, Dr. Matt Hahn. "We have seen significant cycle time reductions resulting from improved information flow across the research cascade and more streamlined coordination of tasks and teams in this collaborative environment."

Integration of the new notebook capabilities with the scientifically aware Accelrys Enterprise Platform supports the combined management of information, tasks and collaboration from early-phase screening and assay development through downstream drug metabolism and pharmacokinetics, ADMET, bioanalytical and in vivo pharmacology. The Platform's extensive scientific Component Collections, built on Accelrys' deep domain expertise in chemistry, biology, materials science, informatics and predictive science, rapidly and cost-effectively deliver advanced imaging, modeling and analytics capabilities supporting scientific workflows from research to development.

Today's drug discovery process requires coordination among multiple teams within the enterprise and, increasingly, across geographical and organizational boundaries. In this challenging R&D environment, the new ELN capabilities from Accelrys improve access to information, foster better collaboration and speed laboratory cycle times by providing:

  • A multidimensional scientific spreadsheet with flexible templates that enable teams to capture, analyze, report and share data from plate-based screening experiments to behavioral studies
  • Enhanced data management, storage and access, enabling rapid data aggregation, searching and reporting for improved insights and faster decisions
  • An integrated system for tracking and optimizing project, study and laboratory workflows. The system supports cascades of services with progression rules for transitioning activities from one stage to the next. Interactive reports record materials and resource usage across the cascades, highlighting bottlenecks and empowering managers to fine-tune resource utilization and allocation

For more information on informatics-driven study orchestration and execution in preclinical development, visit accelrys.com/micro/notebook/preclinical.html. You can also register for the complimentary webinar, " Informatics-Driven Project Execution for In Vivo Pharmacology," scheduled for 8 a.m. PDT, Wednesday, Sept. 12.

About Accelrys, Inc.

Accelrys (NASDAQ:ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,265.99 +109.14 0.64%
S&P 500 2,011.36 +9.79 0.49%
NASDAQ 4,593.4250 +31.2360 0.68%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs